| Go Pro | AZ1 Chatter | IMYO FYI | Tell your friends and family about NICHEY & AZ1 |

The CD-47 targeting therapeutics market is projected to grow at a CAGR of 42.9%, claims Roots Analysis | #cd47 # CD47 Therapeutics # CD47 immunotherapy # cd47 antibody # cd47 companies # CD47 immunotherapy market

Nachrichten und Politik

The CD-47 targeting therapeutics market is projected to grow at a CAGR of 42.9%, claims Roots Analysis

Upon realizing the potential of this novel target, industry stakeholders have initiated several R&D efforts focused on exploiting the use of CD47 as an effective biomarker for the diagnosis and treatment purposes.